← Eichor
Study identifier: NCT06807580 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Progesterone in Gender Affirming Hormone Therapy Study

Condition: Transgender Women  ·  Sponsor: Emory University

PhasePhase 2
Planned participants40
Who can joinMale, 18 Years to 60 Years
Healthy volunteersYes

About this study

This study aims to study the effects of Oral Progesterone in Transgender Women. The primary goal is to study the effect of progesterone on psychological distress and secondarily on sleep quality, breast size, quality of life and gender congruence and cardiovascular risk.

This description comes directly from the study's public registry record.

Talk to the study team

Vin Tangpricha, MD, PhD  ·  404-727-7254  ·  vin.tangpricha@emory.edu

Kayla Tanya Patel, MD

Always discuss trial participation with your own doctor first.

Locations (1)

Emory Transgender ClinicAtlanta, Georgia, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06807580